Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Creating a Culture of Continuous Improvement in Outpatient Laboratories: Effects on Wait Times, Employee Engagement, and Efficiency.

Featherall J, Chaitoff A, Simonetti A, Bena J, Kubiak D, Rothberg M, Roumina K, Hurle N, Henricks W, Yerian L.

Am J Med Qual. 2019 Jul/Aug;34(4):389-397. doi: 10.1177/1062860618808383. Epub 2018 Oct 26.

PMID:
30360634
2.

De Novo Autoimmune Hepatitis Following Liver Transplantation.

Kwon JH, Hanouneh IA, Allende D, Yerian L, Diago T, Eghtesad B, Zein NN.

Transplant Proc. 2018 Jun;50(5):1451-1456. doi: 10.1016/j.transproceed.2018.02.066.

PMID:
29880369
3.

Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.

Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, Fiocchi C, Rieder F.

Aliment Pharmacol Ther. 2018 Apr;47(7):922-939. doi: 10.1111/apt.14526. Epub 2018 Feb 6.

4.

Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery.

Parker BM, Wu J, You J, Barnes DS, Yerian L, Kirwan JP, Schauer PR, Sessler DI.

BMC Obes. 2017 Sep 12;4:32. doi: 10.1186/s40608-017-0168-y. eCollection 2017.

5.

GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.

Enane FO, Shuen WH, Gu X, Quteba E, Przychodzen B, Makishima H, Bodo J, Ng J, Chee CL, Ba R, Seng Koh L, Lim J, Cheong R, Teo M, Hu Z, Ng KP, Maciejewski J, Radivoyevitch T, Chung A, Ooi LL, Tan YM, Cheow PC, Chow P, Chan CY, Lim KH, Yerian L, Hsi E, Toh HC, Saunthararajah Y.

J Clin Invest. 2017 Sep 1;127(9):3527-3542. doi: 10.1172/JCI93488. Epub 2017 Jul 31.

6.

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation.

Issa D, Eghtesad B, Zein NN, Yerian L, Cruise M, Alkhouri N, Adams R, Hanouneh IA.

Int J Organ Transplant Med. 2016;7(1):38-45. Epub 2016 Feb 1.

7.

Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation.

Shiba H, Hashimoto K, Kelly D, Fujiki M, Quintini C, Aucejo F, Uso TD, Yerian L, Yanaga K, Matsushima M, Eghtesad B, Fung J, Miller C.

Hepatol Res. 2016 Oct;46(11):1099-1106. doi: 10.1111/hepr.12661. Epub 2016 Mar 6.

PMID:
26833562
8.

Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai RK, Dasarathy S, McCullough AJ.

BBA Clin. 2014 Sep 20;3:141-5. doi: 10.1016/j.bbacli.2014.09.001. eCollection 2015 Jun.

9.

The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ.

J Gastroenterol Hepatol. 2016 May;31(5):995-1000. doi: 10.1111/jgh.13235.

PMID:
26589761
10.

In Response.

Dasarathy S, Dasarathy J, Khiyami A, Yerian L, McCullough AJ.

J Clin Gastroenterol. 2016 Feb;50(2):181. doi: 10.1097/MCG.0000000000000451. No abstract available.

PMID:
26583270
11.

Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Pai RK, Yerian L, Khiyami A, Sourianarayanane A, Sargent R, Hawkins C, Dasarathy S, McCullough AJ.

Dig Dis Sci. 2015 Jun;60(6):1825-31. doi: 10.1007/s10620-015-3529-8. Epub 2015 Feb 24.

PMID:
25708897
12.

The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.

Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S, Lopez R, Christine CK, Feldstein AE, Alkhouri N.

Dig Dis Sci. 2015 May;60(5):1440-7. doi: 10.1007/s10620-014-3494-7. Epub 2014 Dec 25.

PMID:
25540086
13.

Response to: laboratory assessment may be dependent on the time of liver biopsy.

Goh GB, Pagadala M, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough A, Dasarathy S.

Liver Int. 2015 Jan;35(1):287-8. doi: 10.1111/liv.12659. Epub 2014 Sep 9. No abstract available.

PMID:
25135142
14.

Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease.

Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S.

Liver Int. 2015 Mar;35(3):979-85. doi: 10.1111/liv.12611. Epub 2014 Jul 5.

PMID:
24905085
15.

Impact of throughput optimization on intensive care unit occupancy.

Reddy AJ, Pappas R, Suri S, Whinney C, Yerian L, Guzman JA.

Am J Med Qual. 2015 Jul-Aug;30(4):317-22. doi: 10.1177/1062860614531614. Epub 2014 Apr 22.

PMID:
24755479
16.

Duplicate laboratory test reduction using a clinical decision support tool.

Procop GW, Yerian LM, Wyllie R, Harrison AM, Kottke-Marchant K.

Am J Clin Pathol. 2014 May;141(5):718-23. doi: 10.1309/AJCPOWHOIZBZ3FRW.

PMID:
24713745
17.

Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.

Dasarathy S, Dasarathy J, Khiyami A, Yerian L, Hawkins C, Sargent R, McCullough AJ.

J Clin Gastroenterol. 2015 Feb;49(2):137-44. doi: 10.1097/MCG.0000000000000099.

18.

Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution.

Dugum M, Askar M, Pai RK, Yerian L, Bennett A, McMahon J, Xie H, Eghtesad B, Hanouneh I, Liu X.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):784-91. eCollection 2014.

19.

OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.

Alkhouri N, Berk M, Yerian L, Lopez R, Chung YM, Zhang R, McIntyre TM, Feldstein AE, Hazen SL.

Dig Dis Sci. 2014 Jul;59(7):1617-24. doi: 10.1007/s10620-014-3031-8. Epub 2014 Jan 25.

20.

Three-dimensional print of a liver for preoperative planning in living donor liver transplantation.

Zein NN, Hanouneh IA, Bishop PD, Samaan M, Eghtesad B, Quintini C, Miller C, Yerian L, Klatte R.

Liver Transpl. 2013 Dec;19(12):1304-10. doi: 10.1002/lt.23729. Epub 2013 Oct 21.

21.

Evolution in the diagnosis and treatment of autoimmune pancreatitis: experience from a single tertiary care center.

Yurci A, Stevens T, Shah SN, Law RE, Walsh MR, Yerian L, Liu X.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1317-26. Print 2013.

22.

Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.

Ngeow J, Heald B, Rybicki LA, Orloff MS, Chen JL, Liu X, Yerian L, Willis J, Lehtonen HJ, Lehtonen R, Mester JL, Moline J, Burke CA, Church J, Aaltonen LA, Eng C.

Gastroenterology. 2013 Jun;144(7):1402-9, 1409.e1-5. doi: 10.1053/j.gastro.2013.02.001. Epub 2013 Feb 8.

23.

Validation of whole slide imaging for primary diagnosis in surgical pathology.

Bauer TW, Schoenfield L, Slaw RJ, Yerian L, Sun Z, Henricks WH.

Arch Pathol Lab Med. 2013 Apr;137(4):518-24. doi: 10.5858/arpa.2011-0678-OA. Epub 2013 Jan 16.

PMID:
23323732
24.

Smoothelin expression in the gastrointestinal tract: implication in colonic inertia.

Chan OT, Chiles L, Levy M, Zhai J, Yerian LM, Xu H, Xiao SY, Soffer EE, Conklin JL, Dhall D, Kahn ME, Balzer BL, Amin MB, Wang HL.

Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):452-9. doi: 10.1097/PAI.0b013e31827387c9.

PMID:
23060305
25.

Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case.

Allende D, Dumot J, Yerian L.

Dis Esophagus. 2013 Apr;26(3):314-8. doi: 10.1111/j.1442-2050.2012.01411.x. Epub 2012 Sep 25.

PMID:
23009180
26.

A collaborative approach to lean laboratory workstation design reduces wasted technologist travel.

Yerian LM, Seestadt JA, Gomez ER, Marchant KK.

Am J Clin Pathol. 2012 Aug;138(2):273-80. doi: 10.1309/AJCPE0PI2ENWYWMU.

PMID:
22904140
27.

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.

Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, Feldstein AE, Nobili V.

J Hepatol. 2012 Dec;57(6):1312-8. doi: 10.1016/j.jhep.2012.07.027. Epub 2012 Aug 4.

PMID:
22871498
28.

Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.

Patil DT, Yerian LM.

Liver Transpl. 2012 Oct;18(10):1147-53. doi: 10.1002/lt.23499. Review.

29.

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA.

Gastroenterology. 2012 Aug;143(2):336-46. doi: 10.1053/j.gastro.2012.04.032. Epub 2012 Apr 24.

30.

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.

Zein CO, Lopez R, Fu X, Kirwan JP, Yerian LM, McCullough AJ, Hazen SL, Feldstein AE.

Hepatology. 2012 Oct;56(4):1291-9. doi: 10.1002/hep.25778.

31.

Prevalence of hypothyroidism in nonalcoholic fatty liver disease.

Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R, McCullough AJ.

Dig Dis Sci. 2012 Feb;57(2):528-34. doi: 10.1007/s10620-011-2006-2. Epub 2011 Dec 20.

32.

Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.

Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE.

Liver Int. 2012 Feb;32(2):297-302. doi: 10.1111/j.1478-3231.2011.02639.x. Epub 2011 Sep 8.

PMID:
22097893
33.

Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of Barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems.

Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, Castilla EA, Henricks WH, Schoenfield L, Skacel M, Yerian LM, Rice TW, Bronner MP, Downs-Kelly E.

Am J Surg Pathol. 2012 Jan;36(1):134-41. doi: 10.1097/PAS.0b013e3182354e43.

PMID:
22067333
34.

Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.

Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, Lassman C, Anders RA, Misdraji J, Yerian LM, Xu H, Dhall D, Wang HL.

Hum Pathol. 2012 May;43(5):695-701. doi: 10.1016/j.humpath.2011.06.016. Epub 2011 Sep 19.

35.

Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients.

Wu J, You J, Yerian L, Shiba A, Schauer PR, Sessler DI.

Obes Surg. 2012 Feb;22(2):240-7. doi: 10.1007/s11695-011-0509-8.

PMID:
21901286
36.

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.

Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE, McCullough AJ.

Hepatology. 2011 Nov;54(5):1610-9. doi: 10.1002/hep.24544. Epub 2011 Aug 24.

37.

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P.

Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.

PMID:
21723218
38.

Multifocal cholangiocarcinoma in an explanted liver allograft following retransplant for recurrent primary sclerosing cholangitis.

Law R, Yerian L, Miller C, Dasarathy S.

Trop Gastroenterol. 2010 Oct-Dec;31(4):317-20. No abstract available.

PMID:
21568150
39.

Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project.

Yerian L, Fiocca R, Mastracci L, Riddell R, Vieth M, Sharma P, Franzen S, Fernstrom P, Ruth M.

Dig Dis Sci. 2011 Sep;56(9):2656-65. doi: 10.1007/s10620-011-1624-z. Epub 2011 Mar 2.

PMID:
21365241
40.

Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.

Liu X, Jiang W, Aucejo F, Kim R, Miller C, Byrne M, Lopez R, Yerian L.

Hum Pathol. 2011 Jun;42(6):882-91. doi: 10.1016/j.humpath.2010.10.007. Epub 2011 Feb 2.

PMID:
21292299
41.

Esophagectomy for clinical high-grade dysplasia.

Rice TW, Murthy SC, Mason DP, Rybicki LA, Yerian LM, Dumot JA, Rodriguez CP, Blackstone EH.

Eur J Cardiothorac Surg. 2011 Jul;40(1):113-9. doi: 10.1016/j.ejcts.2010.10.020. Epub 2011 Jan 28.

PMID:
21277216
42.

Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.

Carter-Kent C, Brunt EM, Yerian LM, Alkhouri N, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE.

J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3.

PMID:
21240012
43.

Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection.

Hanouneh IA, Macaron C, Lopez R, Feldstein AE, Yerian L, Eghtesad B, Zein NN.

Int J Organ Transplant Med. 2011;2(2):57-65.

44.

An apoptosis panel for nonalcoholic steatohepatitis diagnosis.

Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE.

J Hepatol. 2011 Jun;54(6):1224-9. doi: 10.1016/j.jhep.2010.08.023. Epub 2011 Feb 12.

45.
46.

Histopathological evaluation of fatty and alcoholic liver diseases.

Yerian L.

J Dig Dis. 2011 Feb;12(1):17-24. doi: 10.1111/j.1751-2980.2010.00472.x. Review.

PMID:
21091934
47.

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Feldstein AE, Lopez R, Tamimi TA, Yerian L, Chung YM, Berk M, Zhang R, McIntyre TM, Hazen SL.

J Lipid Res. 2010 Oct;51(10):3046-54. doi: 10.1194/jlr.M007096. Epub 2010 Jul 14.

48.

Pancreas transplant: recent advances and spectrum of features in pancreas allograft pathology.

Patil DT, Yerian LM.

Adv Anat Pathol. 2010 May;17(3):202-8. doi: 10.1097/PAP.0b013e3181d97635. Review.

PMID:
20418674
49.

Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Rieder F, Biancani P, Harnett K, Yerian L, Falk GW.

Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G571-81. doi: 10.1152/ajpgi.00454.2009. Epub 2010 Mar 18. Review.

50.

Autoimmune hepatitis in children--impact of cirrhosis at presentation on natural history and long-term outcome.

Radhakrishnan KR, Alkhouri N, Worley S, Arrigain S, Hupertz V, Kay M, Yerian L, Wyllie R, Feldstein AE.

Dig Liver Dis. 2010 Oct;42(10):724-8. doi: 10.1016/j.dld.2010.01.002. Epub 2010 Feb 16.

PMID:
20163994

Supplemental Content

Loading ...
Support Center